Back to search

Article

P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cells

2017-07-26

Abstract excerpt

<h4>SUMMARY</h4> CRISPR/Cas9 has revolutionized our ability to engineer genomes and to conduct genome-wide screens in human cells. While some cell types are easily modified with Cas9, human pluripotent stem cells (hPSCs) poorly tolerate Cas9 and are difficult to engineer. Using a stable Cas9 cell line or transient delivery of ribonucleoproteins (RNPs) we achieved an average insertion or deletion efficiency greate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e3d4af30-66fa-50c7-893b-62d7943b683e
DOI
10.1101/168443
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
P53 toxicity is a hurdle to CRISPR/CAS9 screening and engineering in human pluripotent stem cellsDOI 10.1101/168443
Select a neighboring publication to make it the new centre.